Thomson Reuters’ India Innovation Awards 2014 for Sun pharma and Biocon
Biocon and Sun Pharma were honoured at
Thomson Reuters’ India Innovation Awards 2014, announced at the recent launch
of its 2014 State of Innovation India report. This is the second consecutive
year of the study, which analyses innovation in 12 leading sectors based on
patent activity for inventions originating from India, using the Derwent World
Patents Index, Thomson Reuters’ proprietary patent database.
Hi-tech engineering and pharma companies
emerged as front runners of innovation in India. The study showcases twelve
leading sectors and analyses the innovation in each based on patent activity.
“India is an important global innovation hub,
with both local and global organizations conducting critical R&D activities
in India. Patenting activity is growing rapidly and this has a direct impact on
the country’s economic growth,” said Pradeep Lankapalli, Managing Director,
India and head of global operation centres, Thomson Reuters India.
The India Innovation Awards are designed to
recognise innovation and entrepreneurship in India, based on Indian patent
publications. The awards honour the most innovative academic institutions and
commercial enterprises headquartered in India for their spirit of innovation in
R&D
Reacting to the award Kiran Mazumdar-Shaw,
Chairman and Managing Director, Biocon commented, “Our focus on innovation has
enabled Biocon to cross new milestones in the area of drug affordability
through our range of biosimilars and biologics. The Thomson Reuters India
Innovation Award 2014 validates the work that Biocon is doing in our pursuit to
find solutions that heal the world.”
Dr Rajamannar Thennati, Head – R&D, Sun
Pharma, said, ”At Sun Pharma, innovation is the core of our organisation. In our
business, innovation is directly linked to helping patients by providing
medicines at affordable cost. We are focussed on finding solutions to complex
scientific challenges, environmental safety and creating an intellectual asset
for sustained growth.”
Comments
Post a Comment